Evidence map›Paper›PMID 29085037›Full record

ArticleScientific reports2017

Alterations in the host transcriptome in vitro following Rift Valley fever virus infection.

Chelsea Pinkham, Bibha Dahal, Cynthia L de la Fuente, Nicole Bracci, Brett Beitzel, Michael Lindquist, Aura Garrison, Connie Schmaljohn, Gustavo Palacios, Aarthi Narayanan and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Remodelling of P-bodies and the cytoskeleton byThe Journal of general virology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34Molecular therapy : the journal of the American Society of Gene Therapy · 2018
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Chelsea PinkhamNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, 20110, USA.
Bibha DahalNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, 20110, USA.
Cynthia L de la FuenteNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, 20110, USA.
Nicole BracciNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, 20110, USA.
Brett BeitzelUnited States Army Medical Research Institute of Infectious Disease (USAMRIID), Frederick, MD, 21702, USA.
Michael LindquistUnited States Army Medical Research Institute of Infectious Disease (USAMRIID), Frederick, MD, 21702, USA.
Aura GarrisonUnited States Army Medical Research Institute of Infectious Disease (USAMRIID), Frederick, MD, 21702, USA.
Connie SchmaljohnUnited States Army Medical Research Institute of Infectious Disease (USAMRIID), Frederick, MD, 21702, USA.
Gustavo PalaciosUnited States Army Medical Research Institute of Infectious Disease (USAMRIID), Frederick, MD, 21702, USA.ORCID 0000-0001-5062-1938
Aarthi NarayananNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, 20110, USA.
Catherine E CampbellDCE Consulting, Vienna, VA, 22180, USA.
Kylene Kehn-HallNational Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, 20110, USA. kkehnhal@gmu.edu.
George Mason University · USUnited States Army Medical Research Institute of Infectious Diseases · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rift Valley fever virus (RVFV) causes major outbreaks among livestock, characterized by "abortion storms" in which spontaneous abortion occurs in almost 100% of pregnant ruminants. Humans can also become infected with mild symptoms that can progress to more severe symptoms, such as hepatitis, encephalitis, and hemorrhagic fever. The goal of this study was to use RNA-sequencing (RNA-seq) to analyze the host transcriptome in response to RVFV infection. G2/M DNA damage checkpoint, ATM signaling, mitochondrial dysfunction, regulation of the antiviral response, and integrin-linked kinase (ILK) signaling were among the top altered canonical pathways with both the attenuated MP12 strain and the fully virulent ZH548 strain. Although several mRNA transcripts were highly upregulated, an increase at the protein level was not observed for the selected genes, which was at least partially due to the NSs dependent block in mRNA export. Inhibition of ILK signaling, which is involved in cell motility and cytoskeletal reorganization, resulted in reduced RVFV replication, indicating that this pathway is important for viral replication. Overall, this is the first global transcriptomic analysis of the human host response following RVFV infection, which could give insight into novel host responses that have not yet been explored.

Indexed as

Cell Culture TechniquesCell Cycle CheckpointsEpithelial CellsHumansProtein Serine-Threonine KinasesRift Valley FeverRift Valley fever virusRNA, MessengerScaffold Protein ILKSequence Analysis, RNASignal TransductionTranscriptomeViral Nonstructural ProteinsVirus ReplicationProtein Serine-Threonine KinasesRNA, MessengerScaffold Protein ILKViral Nonstructural Proteins

Identifiers

PMID29085037
PMCPMC5662566
OpenAlexW2761582258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.